Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Revenue (Gross)
Ratios

Serina Therapeutics (SER) Revenue (Gross) (2024 - 2025)

Serina Therapeutics (SER) has disclosed Revenue (Gross) for 2 consecutive years, with $68000.0 as the latest value for Q2 2025.

  • Quarterly Revenue (Gross) rose 21.43% to $68000.0 in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $115000.0 through Dec 2025, down 19.58% year-over-year, with the annual reading at $235000.0 for FY2024, 16.96% down from the prior year.
  • Revenue (Gross) hit $68000.0 in Q2 2025 for Serina Therapeutics, up from $47000.0 in the prior quarter.
  • In the past five years, Revenue (Gross) ranged from a high of $87000.0 in Q1 2024 to a low of $47000.0 in Q1 2025.